Clark Capital Management Group Inc. increased its position in Genpact Limited (NYSE:G – Free Report) by 157.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,864,198 shares of the business services provider’s stock after purchasing an additional 1,141,480 shares during the quarter. Clark Capital Management Group Inc. owned approximately 1.08% of Genpact worth $78,091,000 as of its most recent SEC filing.
A number of other large investors also recently added to or reduced their stakes in the business. Private Trust Co. NA boosted its stake in shares of Genpact by 364.2% in the 3rd quarter. Private Trust Co. NA now owns 636 shares of the business services provider’s stock valued at $27,000 after purchasing an additional 499 shares during the last quarter. Quent Capital LLC bought a new stake in shares of Genpact during the third quarter worth approximately $27,000. Westside Investment Management Inc. lifted its holdings in Genpact by 193.5% in the third quarter. Westside Investment Management Inc. now owns 678 shares of the business services provider’s stock valued at $28,000 after buying an additional 447 shares during the period. iSAM Funds UK Ltd acquired a new position in Genpact in the third quarter valued at approximately $29,000. Finally, Johnson Financial Group Inc. bought a new position in Genpact in the third quarter valued at approximately $29,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Genpact Trading Up 0.5%
G opened at $38.33 on Friday. The firm’s fifty day moving average is $41.92 and its two-hundred day moving average is $42.85. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.66 and a current ratio of 1.66. The firm has a market cap of $6.51 billion, a PE ratio of 12.25, a price-to-earnings-growth ratio of 1.13 and a beta of 0.75. Genpact Limited has a twelve month low of $34.79 and a twelve month high of $51.28.
Genpact Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Monday, March 16th will be paid a $0.1875 dividend. The ex-dividend date of this dividend is Monday, March 16th. This is a positive change from Genpact’s previous quarterly dividend of $0.17. This represents a $0.75 dividend on an annualized basis and a yield of 2.0%. Genpact’s payout ratio is presently 21.73%.
Insiders Place Their Bets
In other Genpact news, CEO Balkrishan Kalra sold 2,800 shares of the stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $40.77, for a total value of $114,156.00. Following the completion of the sale, the chief executive officer directly owned 525,007 shares in the company, valued at $21,404,535.39. This represents a 0.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Sameer Dewan sold 15,088 shares of the firm’s stock in a transaction dated Tuesday, January 13th. The stock was sold at an average price of $46.65, for a total value of $703,855.20. Following the sale, the senior vice president directly owned 37,749 shares in the company, valued at approximately $1,760,990.85. This represents a 28.56% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 33,904 shares of company stock worth $1,565,158 over the last ninety days. 3.07% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
A number of analysts have commented on the stock. Susquehanna set a $42.00 target price on shares of Genpact in a report on Friday, February 6th. Weiss Ratings reissued a “hold (c+)” rating on shares of Genpact in a research note on Friday, December 26th. Wall Street Zen cut Genpact from a “buy” rating to a “hold” rating in a research note on Saturday. Needham & Company LLC dropped their price objective on Genpact from $53.00 to $50.00 and set a “buy” rating for the company in a report on Friday, February 6th. Finally, Citigroup raised Genpact from a “hold” rating to a “strong-buy” rating in a research note on Friday, February 13th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $47.29.
View Our Latest Stock Analysis on Genpact
About Genpact
Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.
Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.
Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.
Recommended Stories
- Five stocks we like better than Genpact
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- A personal warning from Martin Weiss (Please read)
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
